We strenghten our team
Vaxxinova is very pleased to announce that Dr. Heike Bigmore (née Scharr) has joined Vaxxinova Autogenous Vaccines GmbH as Key Account Manager for Europe on April 29th 2020. Her primary focus will be on the poultry business. Heike is a very experienced veterinary professional and during her 30-year career she has built a broad expertise […]
Read more →
Further development of autogenous vaccines against Streptococcus suis
Infections with Streptococcus suis are still a big problem worldwide. In addition to management measures to reduce the pathogen pressure in the farm, autogenous (farm-specific) vaccines have been crucial in the fight against S. suis infections for many years. At Vaxxinova, the antigen production and formulation has now been further developed to prevent infections with […]
Read more →
Control of fowl adenovirus (FAdV) with autogenous vaccines
In today’s poultry industry FAdV is mostly seen in young chickens, especially broilers. In these cases, Inclusion body hepatitis (IBH) and Adenoviral gizzard erosions (AGE) are the predominant clinical picture leading to high economic losses worldwide. Inactivated FAdV autogenous vaccines are used to interrupt vertical transmission of FAdV and to deliver maternal antibodies to progenies. […]
Read more →
Vaxxinova®
Vaxxinova® is committed to disease prevention in livestock. We aim to provide a complete set of vaccines and diagnostic services, supported by our global R&D network. Vaxxinova believes in ‘business without borders’, and long term partnerships with livestock veterinarians and animal health professionals. We work together in disease prevention and livestock performonce improvement programs. Our technical teams can advise you on our products and services.